Camp4 Therapeutics Corp Balance Sheet
CAMP|2 years of annual SEC 10-K data (FY2024-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 2 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Total Assets
$118M
FY2025
Cash
$110M
Cash and equivalents
Total Debt
N/A
FY2025
Shareholder Equity
$48M
FY2025
Camp4 Therapeutics Corp had $118M in total assets and $48M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 |
|---|---|---|
| Cash & Equivalents | $109.5M | $64.0M |
| Current Assets | $114.1M | $66.4M |
| PP&E (Net) | - | $3.9M |
| Total Assets | $117.8M | $78.3M |
| Current Liabilities | $15.5M | $9.6M |
| Shareholders' Equity | $47.7M | -$123.7M |